While winter brings relief from the heat and humidity, it also comes with its own set of health challenges, one of which is ...

Does it burn when you pee? Sounds like a UTI. Well, one in two women and 1 in 20 men get UTIs. Here's what to know and how ...

Colder temperatures bring an increase in the risk of developing kidney stones—clusters of crystals that form from minerals ...

The Food and Drug Administration (FDA) has approved Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) ...

The winter season not only sees an increase in joint issues, respiratory illnesses, urinary tract infections (UTIs), and skin ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Tom Ryde from Clitheroe in Lancashire was just 15 when he initially started using the class B drug at weekends. But over time ...

L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.

While 96% of Australian mothers intend to breastfeed, 34% of babies have been given formula in their first month, and ...